This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
protein
product name :
Human GTF3C2 Control Fragment Recombinant Protein
catalog :
RP-108709
quantity :
100 uL
price :
US 259.00
product information
Product Type :
Protein
Product Name :
Human GTF3C2 Control Fragment Recombinant Protein
Catalog # :
RP-108709
Quantity :
100 uL
Price :
US 259.00
Clonality :
Recombinant
Purity :
purified
Reactivity :
Human
Applications :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Species :
Human
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
Required for RNA polymerase III-mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. May play a direct role in stabilizing interactions of TFIIIC2 with TFIIIC1. [UniProt]
Format :
Liquid
Applications w/Dilutions :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Aliases :
1300004C11Rik; 2610510G03Rik; AI225816; AU041069; general transcription factor 3C polypeptide 2; general transcription factor IIIC subunit 2; general transcription factor IIIC, polypeptide 2, beta; general transcription factor IIIC, polypeptide 2, beta 110kDa; Gtf3c2; KIAA0011; mKIAA0011; TF3C-beta; TFIIIC 110 kDa subunit; TFIIIC110; TFIIIC-BETA; Transcription factor IIIC 110 kDa subunit; transcription factor IIIC subunit beta
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments